GENET-news
To stay informed you can subscribe to the GENET-news list.
2007-02-23 | permalink
Patent held by Genentech is revoked by U.S. government
The Patent and Trademark Office has decided to revoke a fundamental patent held by Genentech, the biotechnology company, that was at the center of a recent Supreme Court decision. The patent office’s decision could cost Genentech hundreds of millions of dollars in royalties over the next decade but would save a like amount for rivals that are paying the royalties, including MedImmune, Abbott Laboratories, Johnson & Johnson and ImClone Systems.
Overview
News
2007-02-23 | permalink
Patent held by Genentech is revoked by U.S. government
The Patent and Trademark Office has decided to revoke a fundamental patent held by Genentech, the biotechnology company, that was at the center of a recent Supreme Court decision. The patent office’s decision could cost Genentech hundreds of millions of dollars in royalties over the next decade but would save a like amount for rivals that are paying the royalties, including MedImmune, Abbott Laboratories, Johnson & Johnson and ImClone Systems.
GENET-news & GENET-forum
GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by 
email.
The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the coordinator for membership and subscription.